scholarly journals Surgical Treatment for Tricuspid Valve Infective Endocarditis

Author(s):  
Takashi Murashita
2021 ◽  
Author(s):  
Xie Linfeng ◽  
Chen Xiaodong ◽  
He Jian ◽  
Lin Sixian ◽  
Chen Xingfeng ◽  
...  

Abstract Background In recent years, due to the increase in intravenous drug injection and intracardiac and vascular interventional treatments among drug users, infective endocarditis involving the right heart of the tricuspid valve has gradually increased.At present, there is no systematic report on surgical treatment of tricuspid infective endocarditis. This paper summarizes the experience of surgical treatment of 56 patients with tricuspid infective endocarditis in our hospital and analyzes its clinical effect. Methods From January 2006 to August 2019, 56 cases of tricuspid infective endocarditis treated by tricuspid valve surgery in our hospital were analyzed retrospectively.including 23 cases of tricuspid valvuloplasty (TVP) and 33 cases of tricuspid valve replacement (TVR). All patients were complicated with tricuspid valve vegetations or moderate and severe tricuspid regurgitation and had surgical indications.The perioperative data were collected and followed up for 6 months to 14 years to summarize and analyze the clinical effect of surgical treatment of tricuspid infective endocarditis. Results Compared with TVR group, the CPB time (79.68 ± 19.02min VS 107.39 ± 25.64min, P < 0.01), ACC time (50.29 ± 16.14min VS 65.52 ± 20.62min, P < 0.01), postoperative mechanical ventilation time (18.65 ± 8.18h VS 44.85 ± 57.68h, P < 0.01) and ICU stay time (38.13 ± 21.80h VS 102.64 ± 142.11h, P = 0.015) in TVP group were shorter. The perioperative red blood cell transfusion (4.87 ± 3.81U VS 7.55 ± 5.42U, P < 0.01) and the incidence of postoperative complications (8.7% VS 33.3%, P < 0.01) were lower.Perioperative death occurred in 1 case in the TVR group, and there was no perioperative death in the TVP group, There was no significant difference between the two groups(3.03% VS 0, P = 0.855). A total of 52 cases were followed up for an average of (5.50 ± 3.79) years.The postoperative 3-year, 5-year and 7-year survival rate were 100%,100%,91.7% in TVP group and 95.2%, 93.8% and 87.5%.The 5-year and 10-year reoperation rate were 0%, 0% in TVP group and 6.7%, 20% in TVR group. Conclusion Surgical treatment of severe tricuspid valve endocarditis has achieved good mid-term clinical results, and the rate of avoiding reoperation is better in TVP group than in TVR group.


2013 ◽  
Vol 7 (1) ◽  
pp. 29-34
Author(s):  
DI Lashmanov ◽  
Krishna Bhandari ◽  
VA Chiginev ◽  
VV Pichugin ◽  
EN Zemskova

The objective of this study was to evaluate the clinical features, diagnostic criteria and indications for surgery in patients – drug abusers with tricuspid valve infective endocarditis (TVIE), and outcome of surgical treatment in these patients. From December 1999 to August 2009 35 patients (drug addicts) with TVIE were operated in the department of acquired heart diseases of Cardiac and Vascular Surgery Center, Nizhny Novgorod. 25 males and 10 females aged from 15 to 51 years were included in this study. 3 patients were re-operated due to recurrence of endocarditis. Biological prosthetic valve "Bio-Lab" was used in all patients. Intravenous drug abuse was the cause of the disease in all patients. Acute onset with hectic fever, shivering, profuse sweating, intoxication and development of multi-organ failure were the main clinical features of the disease. Embolism of the peripheral branches of pulmonary artery by septic embolus or micro thrombi were common symptoms. Ultrasound investigation played an important role in diagnosis of TVIE. It was the only criteria for the verification of the diagnosis in patients with fever of unknown origin until the appearance of valve damages and cardiac murmurs. All 35 (100%) patients underwent tricuspid valve replacement (TVR). 3 (8.57%) patients underwent redo TVR because of prosthetic valve endocarditis due to persistent intravenous drug abuse after surgery. The hospital mortality rate was 0%. Acute debut of the disease may be the first clinical feature of tricuspid valve infec­tive endocarditis in drug abusers. Ultrasound investigation is important for early diagnosis and effective treatment. Surgical treatment is indicated in cases of ineffective antibiotic therapy and massive tricuspid valve damages. Tricuspid valve replacement by a biological prosthesis was the treatment of choice in these patients. The use of biological prosthetic valve had good clinical re­sults with low thrombogenic risk and high resistance to infection. Nepalese Heart Journal | Volume 7 | No.1 | November 2010 (special issue) | Page 29-34 DOI: http://dx.doi.org/10.3126/njh.v7i1.8499


2019 ◽  
Vol 292 ◽  
pp. 62-67 ◽  
Author(s):  
Michele Di Mauro ◽  
Massimiliano Foschi ◽  
Guglielmo Mario Actis Dato ◽  
Paolo Centofanti ◽  
Fabio Barili ◽  
...  

2018 ◽  
Vol 19 ◽  
pp. e11-e12
Author(s):  
M. Di Mauro ◽  
G. Actis Dato ◽  
F. Barili ◽  
A. Della Corte ◽  
E. Della Ratta ◽  
...  

2019 ◽  
Vol 48 (1) ◽  
pp. 51-55
Author(s):  
Hironaga Ogawa ◽  
Yuriko Kiriya ◽  
Masahiro Seki ◽  
Yusuke Takei ◽  
Kouji Ogata ◽  
...  

2014 ◽  
Vol 62 (S 01) ◽  
Author(s):  
M. Yilmaz ◽  
A. Häussler ◽  
H. Löblein ◽  
D. Odavic ◽  
M. Genoni ◽  
...  

2004 ◽  
Vol 59 (6) ◽  
pp. 658-662 ◽  
Author(s):  
Akram SALEH ◽  
Keith DAWKINS ◽  
John MONRO

Sign in / Sign up

Export Citation Format

Share Document